A clinical trial has found evidence that the experimental drug tofersen lowers levels of a disease-causing protein in people with an inherited form of amyotrophic lateral sclerosis, or ALS, caused by mutations in the gene SOD1.
Click here for original story, Experimental drug shows early promise against inherited form of ALS, trial indicates
Source: ScienceDaily